The week in one paragraph — A 587-pulse week saw short sellers move with conviction on individual names rather than painting sectors wholesale. Analyst desks were unusually active, with Morgan Stanley re-rating the entire regional banking universe in a single session. Options markets flashed divergent extremes — extreme put buying on utilities and beaten-up industrials, aggressive call accumulation on a handful of recovery stories. The clearest theme: wherever earnings disappointments landed, shorts arrived fast and analysts cut faster.
YOU delivered the week's sharpest single-session move. SI jumped 43.8% in one day to 18.6% of free float — the highest level since tracking began. Availability fell 87% simultaneously. That combination signals rapid new short-selling, not recycled positions.
EROC saw SI surge 27.8% in one session to 8.7 million shares. Weekly gain stands at 36%. Cost to borrow jumped 147% over the same period. Borrow stress and rising short interest together point to a crowded, expensive trade.
CRL added 28% in a single day, pushing SI to 5.05% of float. The spike coincided with a 1.9% price drop. No obvious catalyst — the abruptness of the move warrants attention.
DINO saw SI climb 22% in one day to 5.5% of float. The stock rallied 26% over the past month. Short sellers appear to be fading that rally. CEO uncertainty and refining headwinds are the stated bear case.
GMRS accumulated 24.6% more short interest over the week, reaching 3.3 million shares. The stock fell 7% over the same period despite analyst upgrades and institutional buying. Bears are pushing back against the bullish narrative.
On the covering side, QVCG saw SI plummet 68% in a single session to 175,313 shares. A GoldenTree activist entry and Silver Point exit drove the restructuring of the short book. SECZ covered 31% in one session, down 27% on the week ahead of November earnings.
Morgan Stanley dominated Monday's tape. The bank re-rated at least ten regional banks in one sweep. Upgrades went to MTB (Overweight, PT $304), EWBC (Overweight, PT $160), CFR (Overweight, PT $200 — implying 42% upside), CBSH (upgrade, PT $76), and FLG (Overweight, PT $17). Downgrades hit OZK, CUBI, PB, SFNC, and ZION — all cut to Underweight.
UBS ran a parallel sweep in life science tools. TMO upgraded to Buy with a $730 target — 21% upside. ILMN upgraded to Buy, target $260. WAT upgraded to Buy, target raised 31% to $490. MTD moved the other direction, cut to Neutral.
META received a JPMorgan upgrade to Overweight. Target raised 28% to $820, citing AI infrastructure momentum and regulatory clarity. INTC picked up an Outperform from Northland with a $120 target — 25% above the close at time of publication.
CHWY faced a double downgrade week. Evercore ISI cut to In-Line on Wednesday. JPMorgan followed Thursday, cutting to Neutral and slashing the target 17% to $24. Short interest climbed 12.3% over the week to 9.7% of float.
AMGN absorbed two downgrades in two days — BMO Capital to Market Perform on Monday, HSBC to Hold on Wednesday. Both cuts came despite the stock sitting 12% higher on the month.
NVO was cut to Underweight by Morgan Stanley on GLP-1 competition fears. The stock had already fallen 7.8% over the past month before the call landed.
SNPS received upgrades from both Morgan Stanley (Overweight, $500) and Wells Fargo (Overweight, $475) during the week — notable given the stock was down 11% at the time of the first call.
IRT registered the most extreme reading. Put-to-call ratio hit 8.58 — a 4.3 standard deviation spike above its 20-day average of 3.99. The multifamily REIT options market turned sharply defensive with no obvious single catalyst.
BHP PCR reached 1.44, the highest level in 52 weeks. Mining sector pessimism is building.
ES PCR surged to 1.13 — up 247% from its 20-day average of 0.32. That is an extreme reading for a utility. Combined with the FUTY convergence alert (options skew hitting a two-year high), utilities put buying was a clear theme this week.
COO PCR spiked 4.27 standard deviations above its 20-day mean after a 14.7% single-session collapse on an earnings miss and dual downgrades from Bank of America and Baird. The options market moved fast to price in more downside.
On the bullish side, CQP PCR fell to 0.1708 — the lowest in 52 weeks. Traders are loading calls. ODD dropped to 0.43, a 4.16 standard deviation move below its mean, ahead of earnings — extreme call positioning into a catalyst.
PHR was a split-signal name. Raymond James downgraded to Market Perform. Yet the PCR collapsed to 0.14 — the lowest in a year — as options traders bought calls aggressively against the bearish analyst call.
Regional banks saw the clearest coordinated analyst activity of the week. Morgan Stanley's sweep moved the entire mid-cap banking complex in a single session. SI trends were mixed — ZION SI fell 33.5% over the past month even as the downgrade arrived, suggesting shorts had already repositioned. CBSH saw SI climb 24% in the week despite its upgrade, a divergence worth watching.
Biotech was the busiest sector by pulse count. Short interest spiked on ALNY (up 25% in a day, SI at 5.1% of float). KYMR received a Wolfe Research Outperform upgrade with 14.8% of float short. BHVN was cut to Sector Perform by RBC with SI at 13.4% of float. AMGN absorbed two downgrades as shorts remained modest at 2.29%.
Life science tools saw UBS run bullish on the sector (TMO, ILMN, WAT upgrades) while RVTY was cut to Neutral — a selective call suggesting UBS sees winners and losers rather than a sector-wide re-rating.
Utilities saw consistent bearish options flow. ES, IRT, and FUTY all triggered put-heavy signals. This aligns with the broader convergence alert on ATO, where JPMorgan cut to Neutral and bears built positions in parallel.
Trucking and logistics got a bullish push from Citigroup. CHRW upgraded to Buy, target $185. ODFL upgraded to Buy, target $223. Both imply 20%+ upside. Short interest in CHRW has not yet responded to the call.
AMGN — Two downgrades in two days (BMO Capital, HSBC). Analyst consensus shifting. Short interest modest but the fundamental re-rating is live.
COO — Earnings miss, dual analyst downgrades (Bank of America, Baird), and a 4.27 standard deviation put spike. Three signals aligned in one session. The stock fell 14.7%.
TMO — UBS upgrade collides with rising shorts. Analyst and short-seller conviction are pointing in opposite directions. One side will be wrong.
ETN — UBS upgrade to Buy ($515 target) met with rising short interest. Similar divergence pattern to TMO.
URI — JPMorgan cut to Neutral, target reduced to $1,170. Short sellers added pressure in the same window. Bears and analysts aligned bearishly.
LULU — Short interest returned to pre-earnings peak levels. Bears reloaded after a post-earnings bounce faded.
OXY — Three signals aligned in the same direction. Bears reversed course. Worth monitoring for follow-through.
ATO — JPMorgan downgraded to Neutral, cut target 9%. Bear positions building in parallel. Utility sector pressure continues.
HD — Options turned bullish and shorts covered simultaneously. Rare alignment of positive signals heading into a typically strong seasonal period.
CHWY — Dual downgrades, SI at 9.7% and rising. Further consensus deterioration possible.
YOU — SI at 18.6% of float, highest on record. Availability dropped 87% in a day. Borrow dynamics will determine whether this escalates.
EROC — 36% weekly SI gain, 147% borrow cost increase. An expensive, growing short position.
SNPS — Two upgrades in three days while shorts quietly rebuild. The bull-bear tension is high.
TMO — UBS buy thesis faces short-side pressure. Watching for SI confirmation or reversal.
NIO — Borrow dried up post-earnings as SI climbed. A constrained borrow market with growing short demand is a volatile combination.
DINO — Shorts pressing a stock up 26% on the month. Either the rally fades or a short squeeze develops.
ACVA — Two downgrades in two days (Needham, Barrington). SI at 9.0% of float, highest in four weeks. Analyst capitulation accelerating.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
